Elimination of hepatitis B virus infection in children: experience and challenge in China
Open Access
- 11 October 2021
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Chinese Medical Journal
- Vol. 134 (23), 2818-2824
- https://doi.org/10.1097/cm9.0000000000001791
Abstract
Chronic hepatitis B virus (HBV) infection is a serious health issue because of its severe sequelae. Prevention of mother-to-child transmission (MTCT) of HBV is critical to eliminate chronic HBV infection. Here, we reviewed the progress toward the elimination of HBV infection in children in China in the recent decade. A universal hepatitis B vaccination program started from 2002 has been intensified, with the coverage of timely birth dose >95% of all newborn infants from 2012. Since 2011, China has taken a nationwide program to administer hepatitis B immunoglobulin (HBIG) with free of charge in all neonates of HBV-infected mothers, leading to a significant increment of timely use of HBIG. The prevalence of hepatitis B surface antigen (HBsAg) was declined from around 10% among children in 1980s to 2 × 105 U/mL during the third trimester is increasing, which will further reduce MTCT of HBV. However, there are some challenges in the elimination of HBV infection in children, which need to overcome by the concerted efforts. Nevertheless, it is anticipated that China will achieve the goal set by the World Health Organization that the prevalence of HBsAg in children aged <5 years is ≤0.1% by 2030.Keywords
This publication has 64 references indexed in Scilit:
- Screening of pregnant women for hepatitis B virus surface antigen (HBsAg) and subsequent management, Qiandongnan prefecture, Guizhou, China, 2010Vaccine, 2013
- Identification of risk factors associated with immunoprophylaxis failure to prevent the vertical transmission of hepatitis B virusJournal of Infection, 2013
- Chronic HBV infection among pregnant women and their infants in Shenyang, ChinaVirology Journal, 2013
- The risk factors of transmission after the implementation of the routine immunization among children exposed to HBV infected mothers in a developing area in northwest ChinaVaccine, 2012
- Gaps in the prevention of perinatal transmission of hepatitis B virus between recommendations and routine practices in a highly endemic region: a provincial population-based study in ChinaBMC Infectious Diseases, 2012
- Impact of the implementation of a vaccination strategy on hepatitis B virus infections in China over a 20-year periodInternational Journal of Infectious Diseases, 2012
- Seroprevalence of hepatitis B surface antigen among pregnant women in Jiangsu, China, 17 years after introduction of hepatitis B vaccineInternational Journal of Gynecology & Obstetrics, 2010
- Epidemiological serosurvey of Hepatitis B in China—Declining HBV prevalence due to Hepatitis B vaccinationVaccine, 2009
- Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmissionJAMA, 1987
- PREVENTION OF PERINATALLY TRANSMITTED HEPATITIS B VIRUS INFECTIONS WITH HEPATITIS B IMMUNE GLOBULIN AND HEPATITIS B VACCINEThe Lancet, 1983